Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Microtubule-targeted anticancer agents and apoptosis

Oncogene volume 22, pages 9075–9086 (2003)Cite this article

Abstract

Over the past decade, significant progress has been made in our understanding of the biology of microtubule (MT) assembly into the mitotic spindle during mitosis and the molecular signaling and execution of the various pathways to apoptosis. In the same period, the microtubule-targeted tubulin-polymerizing agents (MTPAs), notably paclitaxel and taxotere, have come to occupy a central role in the treatment of a variety of human epithelial cancers. Following their binding to B-tubulin, MTPAs inhibit MT dynamic instability, cell cycle G2/M phase transition and mitotic arrest of cancer cells. MTPA-induced anti-MT and cell cycle effects trigger the molecular signaling for the mitochondrial pathway of apoptosis. This triggering is orchestrated through different molecular links and determined by the threshold for apoptosis that is set and controlled diversely in various cancer types. The complexity and regulatory potential of the links and the apoptosis threshold are integral to the transformed biology of the cancer cell. The emerging understanding of this biology and how it is influenced by treatment with MTPAs has highlighted novel strategies to further enhance the antitumor activity and overcome resistance to MTPA-induced apoptosis in cancer cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Adams JM and Cory S . (1998). Science, 281, 1322–1326.

  • Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ and George DL . (1999). Oncogene, 18, 5954–5958.

  • Alli E, Bash-Babula J, Yang JM and Hait WN . (2002). Cancer Res., 62, 6864–6869.

  • Altieri DC . (2001). Trends Mol. Med., 7, 542–547.

  • Ambrosini G, Adida C and Altieri D . (1997). Nat. Med., 3, 917–921.

  • Anand S, Penrhyn-Lowe S and Venkitaraman AR . (2003). Cancer Cell, 3, 51–62.

  • Andersen SS . (2000). Trends Cell Biol., 10, 261–267.

  • Baldwin AS . (2001). J. Clin. Invest., 107, 241–246.

  • Bali P and Bhalla K . (2003). Personal communication.

  • Belmont LD, Hyman AA, Sawin KE and Mitchison TJ . (1990). Cell, 62, 579–589.

  • Benimetskaya L, Miller P, Benimetsky S, Maciaszek A, Guga P, Beaucage SL, Wilk A, Grajkowski A, Halperin AL and Stein CA . (2001). Mol. Pharmacol., 60, 1296–1307.

  • Bhalla K, Ibrado AM, Tourkina E, Tang CQ, Mahoney ME and Huang Y . (1993). Leukemia, 7, 563–568.

  • Bischoff JR and Plowman GD . (1999). Cell Biol., 9, 454–459.

  • Blagosklonny MV . (2001). Leukemia, 15, 869–874.

  • Blagosklonny MV and Fojo T . (1999). Int. J. Cancer, 83, 151–156.

  • Blagosklonny MV, Schulte TW, Nguyen P, Trepel J and Neckers L . (1996). Cancer Res., 56, 1851–1854.

  • Blume-Jensen P, Janknecht R and Hunter T . (1998). Curr. Biol., 8, 779–782.

  • Bonni A, Brunet A, West A, Datta SR, Takasu M and Greenberg ME . (1999). Science, 286, 1358–1362.

  • Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM and Strasser A . (1999). Science, 286, 1735–1738.

  • Cassinelli G, Supino R, Perego P, Polizzi D, Lanzi C, Pratesi G and Zunino F . (2001). Int. J. Cancer, 92, 738–747.

  • Chai J, Du C, Wu J, Kyin S, Wang X and Shi Y . (2000). Nature, 406, 855–862.

  • Chai J, Shiozaki E, Srinivasula S, Wu Q, Datta P, Alnemri E and Shi Y . (2001). Cell, 104, 769–780.

  • Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA . (2003). Leukemia, 17, 590–603.

  • Chao DT and Korsmeyer SJ . (1998). Annu. Rev. Immunol., 16, 395–419.

  • Cheetham GMT, Knegtel RMA, Coll JT, Renwick SB, Swenson L, Weber P, Lippke JA and Austen DA . (2002). J. Biol. Chem., 277, 42419–42422.

  • Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed J and Ng SC . (2000). Blood, 2, 235–241.

  • Chen JG and Horwitz SB . (2002). Cancer Res., 62, 1935–1938.

  • Clark AS, West K, Streicher S and Dennis PA . (2002). Mol. Cancer Ther., 1, 707–717.

  • Datta R, Oki E, Endo K, Biedermann V, Ren J and Kufe D . (2000a). J. Biol. Chem., 275, 31733–31738.

  • Datta SR, Brunet A and Greenberg ME . (1999). Genes Dev., 13, 2905–2927.

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241.

  • Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB and Greenberg ME . (2000b). Mol. Cell, 6, 41–51.

  • Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T and Yuan J . (2001). Nat. Cell Biol., 3, 173–182.

  • del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G . (1997). Science, 278, 687–689.

  • Deng CX . (2002). Oncogene, 21, 6222–6227.

  • Dent P and Grant S . (2001). Clin. Cancer Res., 7, 775–783.

  • Derry WB, Wilson L and Jordan MA . (1995). Biochemistry, 34, 2203–2211.

  • Derry WB, Wilson L and Jordan MA . (1998). Cancer Res., 58, 1177–1184.

  • Desai A and Mitchison TJ . (1997). Annu. Rev. Cell Dev. Biol., 13, 83–117.

  • Deveraux Q, Leo E, Stennicke H, Welsh K, Salvesen G and Reed J . (1999). EMBO J., 18, 5242–5251.

  • Deveraux Q and Reed JC . (1997). Genes Dev., 13, 239–252.

  • Deveraux Q, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed JC . (1998). EMBO J., 17, 2215–2223.

  • Dijkers PF, Medema RH, Lammers JW, Koenderman L and Coffer PJ . (2000). Curr. Biol., 10, 1201–1204.

  • Dogterom M and Yurke B . (1997). Science, 278, 856–860.

  • Domina AM, Smith JH and Craig RW . (2000). J. Biol. Chem., 275, 21688–21694.

  • Donaldson KL, Goolsby GL, Kiener PA and Wahl AF . (1994). Cell Growth Differ., 5, 1041–1050.

  • Du C, Fang M, Li Y, Li L and Wang X . (2000). Cell, 102, 33–42.

  • Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L and Sikic BI . (1996). Cancer Res., 56, 1091–1097.

  • Dumontet C and Sikic BI . (1999). J. Clin. Oncol., 17, 1061–1070.

  • Dutertre S, Descamps S and Prigent C . (2002). Oncogene, 21, 6175–6183.

  • Erickson HP and O’Brien ET . (1992). Annu. Rev. Biophys. Biol. Struct., 21, 145–166.

  • Fang G, Chang BS, Kim CN, Perkins C, Thompson CB and Bhalla K . (1998). Cancer Res., 58, 3202–3208.

  • Fedier A, Steiner RA, Schwartz VA, Lenherr L, Haller U and Fink D . (2003). Int. J. Oncol., 22, 1169–1173.

  • Fesik S . (2000). Cell, 103, 273–282.

  • Fuino L, Bali P, Wittmann S, Donapaty S, Guo F, Yamaguchi H, Wang HG, Atadja P and Bhalla K . (2003). Mol. Cancer Ther., 10, 971–984.

  • Giannakakou P, Gussio R, Nogales E, Downing K, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC and Fojo T . (2000). Proc. Natl. Acad. Sci. USA, 97, 2904–2909.

  • Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF and Fojo T . (2002). Proc. Natl. Acad. Sci. USA, 99, 10855–10860.

  • Giannakakou P, Sackett D, Kang YK, Zhan Z, Butters J, Fojo T and Poruchynsky M . (1997). J. Biol. Chem., 272, 17118–17125.

  • Giet R and Prigent C . (1999). J. Cell Sci., 112, 3591–3601.

  • Gigant B, Curmi PA, Martin-Barbey C, Charbaut E, Lachkar S, Lebeau L, Siavoshian S, Sobel A and Knossow M . (2000). Cell, 120, 809–816.

  • Gonçalves A, Braguer D, Kamath K, Martello L, Briand C, Horwitz S, Wilson L and Jordan MA . (2001). Proc. Natl. Acad. Sci. USA, 98, 11737–11741.

  • Gross A, McDonnell J and Korsmeyer S . (1999). Genes Dev., 13, 1899–1911.

  • Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C and Bhalla K . (2002). Blood, 99, 3419–3426.

  • Haggarty SJ, Koeller KM, Wong JC, Grozinger CM and Schreiber SL . (2003). Proc. Natl. Acad. Sci. USA, 100, 4389–4394.

  • Haldar S, Basu A and Croce CM . (1998). Cancer Res., 58, 1609–1615.

  • Haldar S, Jena N and Croce DM . (1995). Proc. Natl. Acad. Sci. USA, 92, 4507–4511.

  • Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD and Korsmeyer SJ . (1999). Mol. Cell, 3, 413–422.

  • Harari D and Yarden Y . (2000). Oncogene, 19, 6102–6114.

  • Hawkins DS, Demers GW and Galloway DA . (1996). Cancer Res., 56, 892–898.

  • He L, Huang Yang CP and Horwitz SB . (2001). Mol. Cancer Ther., 1, 3–10.

  • Hegde R, Srinivasula S, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos A, Fernandes-Alnemri and Alnemri E . (2001). J. Biol. Chem., 277, 432–438.

  • Hengartner M . (2000). Nature, 407, 770–775.

  • Howard J and Hyman AA . (2003). Nature, 422, 753–758.

  • Hu L, Hofmann J, Lu Y, Mills GB and Jaffe RB . (2002). Cancer Res., 62, 1087–1092.

  • Huang D and Strasser A . (2000). Cell, 103, 839–842.

  • Huang Y and Fan W . (2002). Mol. Pharmacol., 61, 105–113.

  • Huang Y, Fang Y, Dziadyk JM, Norris JS and Fan W . (2002). Oncol. Res., 13, 113–122.

  • Huang Y, Johnson KR, Norris JS and Fan W . (2000). Cancer Res., 60, 4426–4432.

  • Huang Y, Park Y, Rich R, Segal D, Myszka D and Wu H . (2001). Cell, 104, 781–790.

  • Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A and Bhalla K . (1997). Breast Cancer Res. Treatment, 42, 73–81.

  • Iancu C, Mistry SJ, Arkin S and Atweh GF . (2000). Cancer Res., 60, 3537–3541.

  • Ibrado AM, Huang Y, Fang G and Bhalla K . (1996). Cell Growth Differ., 7, 1087–1094.

  • Ibrado AM, Kim CN and Bhalla K . (1998).

  • Ibrado AM, Liu L and Bhalla K . (1997). Cancer Res., 57, 1109–1115.

  • Inoue S and Salmon ED . (1995). Mol. Biol. Cell, 6, 1619–1640.

  • Isaacs JS, Wanping X and Neckers L . (2003). Cancer Cell, 3, 213–217.

  • Ito T, Deng X, Carr B and May WS . (1997). J. Biol. Chem., 272, 11671–11673.

  • Jansen B, Schlagbauer-Wadl H, Brown B, Bryan R, van Elsas A, Muller M, Wolff K, Eicher H and Pehamberger H . (1998). Nat. Med., 4, 232–234.

  • Jordan MA . (2002). Curr. Med. Chem. Anti-Cancer Agents, 2, 1–17.

  • Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L . (1996). Cancer Res., 56, 816–825.

  • Karsenti E and Vernos I . (2001). Science, 294, 543–547.

  • Kavallaris M, Burkhart CA and Horwtiz SB . (1999). Br. J. Cancer, 80, 1020–1025.

  • Kavallaris M, Kuo DY-S, Burkhart CA, Regl DL, Norris MD, Haber M and Horwitz SB . (1997). J. Clin. Invest., 100, 1282–1293.

  • Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G and Bhalla K . (1997). Cancer Res., 57, 3115–3120.

  • Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L, Schmidt M, Mills GB, Mendelsohn J and Fran Z . (2003). Oncogene, 22, 3205–3212.

  • Konishi Y, Lehtinen M, Donovan N and Bonni A . (2002). Mol. Cell, 9, 1005–1015.

  • Kowalski R, Giannakakou P and Hamel E . (1997). J. Biol. Chem., 272, 2534–2541.

  • Kroemer G and Reed J . (2000). Nat. Med., 6, 513–519.

  • Lamendola DE, Duan Z, Penson RT, Oliva E and Seiden MV . (2003). Anticancer Res., 23, 681–686.

  • Lee FYF, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC and Kramer RA . (2001). Clin. Cancer Res., 7, 1429–1437.

  • Lee LF, Li G, Templeton DJ and Ting JP . (1998). J. Biol. Chem., 273, 28253–28260.

  • Lee S, Yang W, Lan KH, Sellappan S, Klos K, Hortobagyi G, Hung MC and Yu D . (2002). Cancer Res., 62, 5703–5710.

  • Lei K and Davis RJ . (2003). Proc. Natl. Acad. Sci. USA, 100, 2432–2437.

  • Li F, Ackermann E, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC . (1999). Nat. Cell Biol., 1, 461–466.

  • Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC . (1998). Nature, 396, 580–584.

  • Ling Y-H, Tornos C and Perez-Soler R . (1998). J. Biol. Chem., 273, 18984–18991.

  • Liu Z, Sun C, Olejniczak E, Meadows RP, Betz SF, Oost T, Herrmann J, Wu JC and Fesik SW . (2000). Nature, 408, 1004–1012.

  • MacKeigan JP, Collins TS and Ting JP . (2000). J. Biol. Chem., 275, 38953–38956.

  • Maeno K, Ito K, Hama Y, Shingu K, Kimura M, Sano Nakagomi H, Tsuchiya S and Fujimori M . (2003). Cancer Lett., 198, 89–97.

  • Martello LA, Verdier-Pinard P, Shen H-J, He L, Torres K, Orr GA and Horwitz SB . (2003). Cancer Res., 63, 1207–1213.

  • May WS, Tyler PG, Ito T, Armstrong DK, Qatasha KA and Davidson NE . (1994). J. Biol. Chem., 269, 26865–26870.

  • McDaid HM and Horwitz SB . (2001). Mol. Pharmacol., 60, 290–301.

  • Miller KD and Sledge Jr GW . (1999). Cancer Invest., 17, 121–136.

  • Minotti AM, Barlow SB and Cabral F . (1991). J. Biol. Chem., 266, 3987–3994.

  • Mitchison T and Kirschner M . (1984). Nature, 312, 237–242.

  • Mitchison TJ . (1993). Science, 261, 1044–1047.

  • Monzo M, Rosell R, Sanchez JJ, Lee JS, O'Brate A, Gonzalez-Larriba JL, Alberola V, Lorenzo JC, Nunez L, Ro JY and Martin C . (1999). J. Clin. Oncol., 17, 1786–1793.

  • Muchmore S, Chen J, Jakob C, Zakula D, Mayayoshi E, Wu W, Zhang H, Li F, Ng SC and Altieri D . (2000). Mol. Cell, 6, 173–182.

  • Mullan PB, Quinn JE, Gilmore PM, McWilliams S, Andrews H, Gervin C, McCabe N, McKenna S, White P, Song YH, Maheswaran S, Liu E, Haber DA, Johnston PG and Harkin DP . (2001). Oncogene, 20, 6123–6131.

  • Murphy M, Hinman A and Levine AJ . (1996). Genes Dev., 10, 2971–2980.

  • Neckers L . (2002). Trends Mol. Med., 8, 55–61.

  • Nguyen DM, Chen A, Mixon A and Schrump DS . (1999). J. Thorac. Cardiovasc. Surg., 118, 908–915.

  • Nicoletti MI, Valoti G, Giannakakou P, Zhan Z, Kim JH, Lucchini V, Landoni F, Mayo JG, Giavazzi R and Fojo T . (2001). Clin. Cancer Res., 7, 2912–2922.

  • Nogales E, Whittaker M, Milligan RA and Downing KH . (1999). Cell, 96, 79–88.

  • O'Connor D, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio P and Altieri D . (2000). Proc. Natl. Acad. Sci. USA, 97, 13103–13107.

  • O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S and Huang DC . (1998). EMBO J., 17, 384–395.

  • O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace Jr AJ and Kohn KW . (1997). Cancer Res., 57, 4285–4300.

  • Ohta S, Nishio K, Ohmori T, Kubota N, Takeda Y, Kanzawa F, Takahashi T and Saijo N . (1993). The Mechanism and New Approach to Drug Resistance of Cancer Cells, Miyazaki T, Takaku F and Sakurada K (eds) Elsevier Science: New York, pp. 209–212.

    Google Scholar 

  • Olie R, Simões-Wüst AP, Baumann B, Leech SH, Fabbro D, Stahel RA and Zangemeister-Wittke U . (2000). Cancer Res., 60, 2805–2809.

  • Orlowski RZ and Baldwin Jr AS . (2002). Trends Mol. Med., 8, 385–389.

  • Paez J and Sellers WR . (2003). Cancer Treat. Res., 115, 145–167.

  • Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet Jr RJ, Sledge Jr GW and Nakshatri H . (2000). Oncogene, 19, 4159–4169.

  • Perkins C, Fang G, Kim C and Bhalla K . (2000). Cancer Res., 60, 1645–1653.

  • Perkins C, Kim CN, Fang G and Bhalla K . (1998). Cancer Res., 58, 4561–4566.

  • Poruchynsky MS, Wang EW, Rudin CM and Blagosklonny MV . (1998). Cancer Res., 58, 3331–3338.

  • Putcha GV, Moulder KL, Golden JP, Bouillet P, Adams JA, Strasser A and Johnson EM . (2001). Neuron, 29, 615–628.

  • Rao S, He L, Chakravarty S, Ojima I, Orr GA and Horwitz SB . (1999). J. Biol. Chem., 274, 37990–37994.

  • Rao S, Krauss NW, Heerding JM, Swindell CS, Ringel I, Orr G and Horwitz SB . (1994). J. Biol. Chem., 269, 3132–3134.

  • Reed F and Bischoff J . (2000). Cell, 102, 545–548.

  • Reider CL and Salmon ED . (1998). Trends Cell Biol., 8, 310–318.

  • Riedl S, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik S, Liddington R and Salvesen G . (2001). Cell, 104, 791–800.

  • Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA and Makowski L . (1999). J. Mol. Biol., 285, 197–203.

  • Roghi C, Giet R, Uzbekov R, Morin N, Chartrain I, Le Guellec R, Couturier A, Doree M, Philippe M and Prigent C . (1998). J. Cell Sci., 111, 557–572.

  • Rosen EM, Fan S, Pestell RG and Goldberg ID . (2003). J. Cell. Physiol., 196, 19–41.

  • Rowinsky EK and Donehower RC . (1995). N. Engl. J. Med., 332, 1004–1014.

  • Rowinsky EK and Donehower RC . (2001). Cancer Chemotherapy & Biotherapy: Principles and Practice, Chabner BA and Longo DL (eds) Lippincott Williams & Wilkins: Philadelphia, pp. 329–372.

    Google Scholar 

  • Rudner AD and Murray AW . (1996). Curr. Opin. Cell Biol., 8, 773–780.

  • Å ale S, Sung R, Shen P, Yu K, Wang Y, Duran GE, Kim JH, Fojo T, Oefner PJ and Sikic BI . (2002). Mol. Cancer Ther., 1, 215–225.

  • Sammak PJ and Borisy GG . (1988). Nature, 332, 724–726.

  • Sasaki H, Sheng Y, Kotsuji F and Tsang B . (2000). Cancer Res., 60, 565–566.

  • Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB and Fesik SW . (1997). Science, 275, 983–986.

  • Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD and Pietenpol JA . (1998). J. Biol. Chem., 273, 30777–30784.

  • Schandl CA, Priest DG and Willingham MC . (1996). Cell. Pharmacol., 3, 367–372.

  • Seidman R, Gitelman I, Sagi O, Horwitz SB and Wolfson M . (2001). Exp. Cell Res., 268, 84–92.

  • Sen S, Zhou H and White RA . (1997). Oncogene, 14, 2195–2200.

  • Shingu T, Yamada K, Hara N, Moritake K, Osago H and Terashima M . (2003). Cancer Res., 63, 4044–4047.

  • Shinjyo T, Kuribara R, Inukai T, Hosoi H, Kinoshita T, Miyajima A, Houghton PJ, Look AT, Ozawa K and Inaba T . (2001). Mol. Cell. Biol., 21, 854–864.

  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and McGuire WL . (1989). Science, 244, 707–712.

  • Solit DB, Basso AD, Olshen AB, Scher HI and Rosen N . (2003). Cancer Res., 63, 2139–2144.

  • Srinivasula S, Datta P, Fan X, Fernances-Alnemri T, Huang Z and Alnemri E . (2000). J. Biol. Chem., 275, 36152–36157.

  • Srinivasula S, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee R, Robbins P, Fernandes-Alnemri T, Shi Y and Alnemri E . (2001). Nature, 410, 112–116.

  • Srinivasula SM, Ahmad M, Fernandes-Almenri T and Almenri ES . (1998).

  • Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T and Alnemri ES . (2003). J. Biol. Chem., 34, 31469–31472.

  • Srivastava RK, Mi Q-S, Hardwick JM and Longo DL . (1999). Proc. Natl. Acad. Sci. USA, 96, 3775–3780.

  • Stachel SJ, Biswas K and Danishefsky SJ . (2001). Curr. Pharm. Des., 7, 1277–1290.

  • Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM and Medema RH . (2002). J. Immunol., 168, 5024–5031.

  • Strasser A, O’Connor L and Dixit V . (2000). Annu. Rev. Biochem., 69, 217–247.

  • Strobel T, Swanson L, Korsmeyer S and Cannistra SA . (1996). Proc. Natl. Acad. Sci. USA, 93, 14094–14099.

  • Strobel T, Tai YT, Korsmeyer S and Cannistra SA . (1998). Oncogene, 17, 2419–2427.

  • Tai YT, Storbel T, Kufe D and Cannistra SA . (1999). Cancer Res., 59, 2121–2126.

  • Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S, Fang D, Nagata Y, Liu J, Arlinghaus R, Hung MC and Yu D . (2002). Mol. Cell, 9, 993–1104.

  • Tang C, Willingham MC, Reed JC, Miyashita T, Tourkina E, Ponnathpur V, Huang Y, Ray S, Mahoney ME, Bullock G and Bhalla K . (1994). Leukemia, 8, 1960–1969.

  • Tassin A and Bornens M . (1999). Biol. Cell, 91, 343–354.

  • Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costa F, Boland CR and Venuta S . (2003). Br. J. Cancer, 88, 1285–1291.

  • Thangaraju M, Kaufmann SH and Couch FJ . (2000). J. Biol. Chem., 275, 33487–33496.

  • Vander Heiden M and Thompson C . (1999). Nat. Cell Biol., 1, E209–E216.

  • Vasey PA, Jones NA, Jenkins S, Dive C and Brown R . (1996). Mol. Pharmacol., 50, 1536–1540.

  • Vilenchik M, Raffo AJ, Benimetskaya L, Shames D and Stein CA . (2002). Cancer Res., 62, 2175–2183.

  • Vivanco I and Sawyers CL . (2002). Nat. Rev. Cancer, 2, 489–501.

  • Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW and Galloway DA . (1996). Nat. Med., 2, 72–79.

  • Wall NR, O’Connor DS, Plescia J, Pommier Y and Altieri DC . (2003). Cancer Res., 63, 230–235.

  • Walter AO, Seghezzi W, Korver W, Sheung J and Lees E . (2000). Oncogene, 19, 4906–4916.

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS . (1998a). Science, 281, 1680–1683.

  • Wang H-G and Bhalla K . (2003). Personal communication.

  • Wang J, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce C, Alnemri E, Korngold R and Huang Z . (2000a). Cancer Res., 60, 1498–1502.

  • Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula S, Croce C, Alnemri E and Huang Z . (2000b). Proc. Natl. Acad. Sci. USA, 97, 7124–7129.

  • Wang S, Wang Z, Boise L, Dent P and Grant S . (1999a). Biochem. Biophys. Res. Commun., 259, 67–72.

  • Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, Ichijo H and Wimalasena J . (1999b). J. Biol. Chem., 274, 8208–8216.

  • Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T and Wimalasena J . (1998b). J. Biol. Chem., 273, 4928–4939.

  • Wang TH, Wang HS and Soong YK . (2000c). Cancer, 88, 2619–2628.

  • Wang X . (2001). Genes Dev., 15, 2922–2933.

  • Wei M, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ . (2000). Genes Dev., 14, 2060–2071.

  • Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ . (2001). Science, 292, 727–730.

  • Widmann C, Gibson S, Jarpe MB and Johnson GL . (1999). Physiol. Rev., 79, 143–180.

  • Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Huang M, Jove R, Wang HG and Bhalla K . (2003). Cancer Res., 63, 93–99.

  • Wittmann S and Bhalla K . (2003). Personal conversation.

  • Woods CM, Zhu J, McQueney PA, Bollag D and Lazsarides E . (1995). Mol. Med., 1, 506–526.

  • Yamaguchi H, Paranawithana S, Lee M, Huang Z, Bhalla K and Wang HG . (2002). Cancer Res., 62, 466–471.

  • Yamaguchi H and Wang H-G . (2002). J. Biol. Chem., 277, 41604–41612.

  • Yamamoto K, Ichijo H and Korsmeyer SJ . (1999). Mol. Cell. Biol., 19, 8469–8478.

  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X . (1997). Science, 275, 1129–1132.

  • Yang Q-H, Church-Hajduk R, Ren J, Newton ML and Du C . (2003). Genes Dev., 17, 1487–1496.

  • Yang Y, Fang S, Jensen J, Weissman A and Ashwell J . (2000). Science, 288, 874–877.

  • Yu C, Wang S, Dent P and Grant S . (2001). Mol. Pharmacol., 60, 143–154.

  • Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ and Hung MC . (1998). Mol. Cell, 2, 581–591.

  • Yu D, Liu B, Tan M, Li J, Wang S-S and Hung M-C . (1996). Oncogene, 13, 1359–1365.

  • Zangemeister-Wittke U, Leech S, Olie R, Simoes-Wust AP, Gautschi O, Luedke G, Natt F, Haner R, Martin P, Hall J, Nalin C and Stahel R . (2000). Clin. Cancer Res., 6, 2547–2555.

  • Zha J, Harada H, Yang E, Jockel J and Korsmeyer SJ . (1996). Cell, 87, 619–628.

  • Zhang CC, Yang JM, White E, Murphy M, Levine A and Hait WN . (1998). Oncogene, 16, 1617–1624.

  • Zhou C, Smith JL and Liu J . (2003). Oncogene, 22, 2396–2404.

  • Zhou H, Kuang J, Zhong L, Kuo WL, Gray J, Sahin A, Brinkley BR and Sen S . (1998). Nat. Genet., 20, 189–193.

  • Zong WX, Lindsten T, Ross A, MacGregor G and Thompson C . (2001). Genes Dev., 15, 1481–1486.

  • Zou H, Li Y, Liu X and Wang X . (1998). J. Biol. Chem., 274, 11549–11556.

Download references

Author information

Authors and Affiliations

  1. Department of Interdisciplinary Oncology, Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, MRC 3 East, Room 3056, Tampa, FL, USA

    Kapil N Bhalla

Authors
  1. Kapil N Bhalla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kapil N Bhalla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhalla, K. Microtubule-targeted anticancer agents and apoptosis. Oncogene 22, 9075–9086 (2003). https://doi.org/10.1038/sj.onc.1207233

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207233

Keywords

This article is cited by

Search

Advanced search

Quick links